Forma Therapeutics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Forma Therapeutics Holdings generated cash of -$149,787,000, which is less than the previous year. Cash used in financing activities reached the amount of -$459,000 last year. Net change in cash is therefore -$205,621,000.
Cash Flow
| 2018 | -132.83M | 99.09M | 0 |
|---|---|---|---|
| 2019 | -34.49M | 69.41M | 54.80M |
| 2020 | -95.41M | -345.82M | 552.60M |
| 2021 | -149.78M | -55.37M | -459K |
FMTX Cash Flow Statement (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Cash at beginning of period | 285.15M | 173.79M | 84.06M | 117.8M |
Operating activities | ||||
Net income | -172.96M | -70.41M | -34.79M | 5.29M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.56M | 1.27M | 2.66M | 3.52M |
Stock-based compensation expense | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 227K | 82.35M | -56.27M |
Inventories | 0 | -11.49M | 12.00M | -12.14M |
Accounts payable | -173K | 933K | -2.77M | 2.28M |
Cash generated by operating activities | -149.78M | -95.41M | -34.49M | -132.83M |
Investing activities | ||||
Purchases Of Investments | -578.50M | -479.63M | -106.58M | -118.33M |
Investments In Property Plant And Equipment | -4.17M | -249K | -529K | -3.39M |
Acquisitions Net | 0 | 17.84M | 0 | 0 |
Cash generated by investing activities | -55.37M | -345.82M | 69.41M | 99.09M |
Financing activities | ||||
Common Stock Issued | 0 | 552.47M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -259K | 0 | 0 |
Repayments of term debt | 0 | -3.73M | 0 | 0 |
Cash used in financing activities | -459K | 552.60M | 54.80M | 0 |
Net Change In Cash | -205.62M | 111.36M | 89.73M | -33.73M |
Cash at end of period | 79.53M | 285.15M | 173.79M | 84.06M |
| Data source | Data source |